<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is a <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">heritable disorder</z:e> of the connective tissue which affects the cardiovascular, ocular, and skeletal system </plain></SENT>
<SENT sid="1" pm="."><plain>The cardiovascular manifestation with <z:hpo ids='HP_0002616'>aortic root dilatation</z:hpo>, <z:hpo ids='HP_0001659'>aortic valve regurgitation</z:hpo>, and <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> has a prevalence of 60% to 90% and determines the premature <z:hpo ids='HP_0011420'>death</z:hpo> of these patients </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty-four percent of the patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> will have serious cardiovascular complications requiring surgery in the first 10 years after diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>Before aortic surgery became available, the majority of the patients died by the age of 32 years </plain></SENT>
<SENT sid="4" pm="."><plain>Introduction in the aortic surgery techniques caused an increase of the 10 year survival rate up to 97% </plain></SENT>
<SENT sid="5" pm="."><plain>The purpose of this article is to give an overview about the feasibility and outcome of stent-graft placement in the descending thoracic aorta in Marfan patients with previous aortic surgery </plain></SENT>
</text></document>